Correspondence 0001213900-22-070583 from Clearmind Medicine Inc. (CMND)
Clearmind Medicine Inc.
Date: Nov. 9, 2022 · CIK: 0001892500 · Accession: 0001213900-22-070583
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-265900
Letter
Clearmind Medicine Inc
101 – 1220 West 6th Avenue
Vancouver, British Columbia V6H1A5
November 9, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: Clearmind Medicine Inc. (CIK 0001892500)
Registration Statement No. 333-265900 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
Clearmind Medicine Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on November 10, 2022 at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig LLP, by calling David Huberman at (212) 801-9221. The Company hereby authorizes Mr. Huberman to orally modify or withdraw this request for acceleration.
Very truly yours,
CLEARMIND MEDICINE
INC.
Show Raw Text
CORRESP
1
filename1.htm
Clearmind Medicine Inc
101 – 1220 West 6th Avenue
Vancouver, British Columbia V6H1A5
November 9, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Clearmind Medicine Inc. (CIK 0001892500)
Registration Statement No. 333-265900 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
Clearmind Medicine Inc. (the “Registrant”)
hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities
Act of 1933, as amended (the “Securities Act”), so that it may become effective on November 10, 2022 at 4:30 p.m.,
Eastern Time, or as soon thereafter as is practicable.
The undersigned respectfully requests
that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig LLP, by calling
David Huberman at (212) 801-9221. The Company hereby authorizes Mr. Huberman to orally modify or withdraw this request for acceleration.
Very truly yours,
CLEARMIND MEDICINE
INC.
By:
/s/ Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer